Format
Sort by

Send to:

Choose Destination

Results: 5

1.

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Möslein G, Vasen HF, Coaker J, Phillips RK, Bülow S, Mathers JC; International CAPP consortium.

Cancer Prev Res (Phila). 2011 May;4(5):655-65. doi: 10.1158/1940-6207.CAPR-11-0106.

2.

Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.

Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlström J, Martinsson T, Nordling M, Hultcrantz R.

Gastroenterology. 2001 Nov;121(5):1127-35.

PMID:
11677205
3.

Outcome of primary and secondary ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis.

Björk J, Akerbrant H, Iselius L, Svenberg T, Oresland T, Påhlman L, Hultcrantz R.

Dis Colon Rectum. 2001 Jul;44(7):984-92.

PMID:
11496079
4.

Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis.

Björk JA, Akerbrant HI, Iselius LE, Hultcrantz RW.

Dis Colon Rectum. 2000 Dec;43(12):1719-25.

PMID:
11156457
5.

Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females.

Björk J, Akerbrant H, Iselius L, Alm T, Hultcrantz R.

Scand J Gastroenterol. 1999 Dec;34(12):1230-5.

PMID:
10636071
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk